BMAL1 and sarcopenia: Initial characterization of Bmal1−/− mice demonstrated a reduced lifespan and an acceleration in age-associated phenotypes, including sarcopenia, subcutaneous fat loss, and cataracts [23] as well as increased SA-β-gal staining in multiple tissue types suggestive of an increased senescent cell burden [39].